RIP kinase inhibitor RIPK1-IN-4, Purity ≥98%

Cat. No.: X23-10-ZQ168

RIP kinase inhibitor RIPK1-IN-4, Purity ≥98%

Synonym: 1481641-08-0; RIPK1-IN-4; 1-[4-(1-Aminoisoquinolin-5-Yl)phenyl]-3-(5-tert-Butyl-1,2-Oxazol-3-Yl)urea; 1-(4-(1-Aminoisoquinolin-5-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea; RIP kinase inhibitor

  • CAS Number: 1481641-08-0
  • Compound CID: 71816195
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RIPK1-IN-4 is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Weight
401.46
Molecular Formula
C23H23N5O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
RIPK1-IN-4 can be used to explore the inhibition of RIPK1 and its effects on inflammatory diseases.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0